SciSparc (SPRC) Asset Utilization Ratio (2017 - 2022)
SciSparc (SPRC) posted Asset Utilization Ratio of 0.06 for Q4 2022, down 29.61% sequentially from 0.09 in Q3 2022.
SciSparc (SPRC) Asset Utilization Ratio (2017 - 2022) Analysis & Trends
SciSparc has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.06 in Q4 2022.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.06 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.06 (changed N/A YoY) and the FY2025 annual result came in at 0.1, down 21.47% from the prior year.
- Asset Utilization Ratio slipped to 0.06 in Q4 2022 per SPRC's latest filing, from 0.09 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 1.03 in Q2 2018 and troughed at 0.06 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2018 | 1.03 |
| Mar 31, 2018 | 0.82 |
| Dec 31, 2017 | 0.56 |
| Sep 30, 2017 | 0.32 |
| Jun 30, 2017 | 0.26 |